Sensole Orthotics

Company Overview

Snapshot

Founded in April 2024 by Dr. Dov Rubin, Peleg Aharoni, and Nir Babo, Sensole Orthotics operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its AI-driven bio-adaptation technology for custom insole design.

Business overview

Sensole Orthotics is developing bio-adaptation technology that leverages AI and biofeedback for custom orthotic insole design. The company's platform performs a complete biofeedback scan directly under the customer's feet to eliminate human error and maximize satisfaction. Sensole Orthotics operates within the Health Tech & Life Sciences sector, specifically targeting the Medical Devices industry and Medical Products market with its wellness and orthopedics solutions.

Company Intelligence Q&A

What is Sensole Orthotics' core technology?

Sensole Orthotics is developing real-time Bio-Adaptation technology that uses AI and biofeedback for custom insole design, aiming to eliminate human error and maximize user satisfaction.

When was Sensole Orthotics founded and by whom?

Sensole Orthotics was founded in April 2024 by Dr. Dov Rubin, Peleg Aharoni, and Nir Babo.

What markets does Sensole Orthotics target?

Sensole Orthotics targets the global market, focusing on the Healthcare & Life Sciences sector, particularly the Medical Devices Industry and Medical Products.

What is the current product stage of Sensole Orthotics?

Sensole Orthotics is currently in the R&D product stage, developing its AI-driven custom insole technology.

What business models does Sensole Orthotics employ?

Sensole Orthotics primarily utilizes a B2B business model for its AI-powered orthotic insole solutions.